Ambasing: Propesor Villar - Maawa po kayo sa pasyente
1 May 2012, 12:23 pm
A PERSON with epilepsy remains admitted in the hospital after a stroke. The patient’s seizures were previously relatively controlled with once weekly seizures while on Valproic Acid – Levetiracetam combination.

What is Parkinson's disease?
28 April 2012, 8:18 am
Parkinson's is a degenerative, neurological disorder that predominately affects movement. According to the National Parkinson Foundation, between 50,000 and 60,000 people are diagnosed with Parkinson's every year.

Orion Sues Mylan In US To Enforce Parkinson's Drug Patents
27 April 2012, 5:10 am
Orion Sues Mylan In US To Enforce Parkinson's Drug Patents

Orion sues Mylan in the U.S. to enforce its U.S. patents covering the proprietary drug Stalevo®
26 April 2012, 11:27 am
Orion Corporation         Stock Exchange Release         26  April  2012 at  19.25  EEST Company states generic competition is not imminent based on this application. Orion Corporation has filed a patent ...

Research and Markets: Parkinson's Disease Therapeutics - Parkinson's Disease (PD) Therapeutics Market is Forecast to ...
25 April 2012, 8:08 am
Research and Markets has announced the addition of GlobalData 's new report "Parkinson's Disease Therapeutics

Wockhardt launches authorized generic of Parkinson's drug
24 April 2012, 4:54 am
Kolkata, Apr 24 : Pharmaceutical and biotechnology major Wockhardt has launched an authorized generic version of four strengths (50mg, 75mg, 125mg and 200mg) of the triple-drug combination product containing Levodopa, carbidopa and Entacapone, which are used in treatment of Parkinson's disease.

Clinical Trial at Evergreen Healthcare Shows Intestinal Gel Reduces Symptoms of Advanced Parkinson's Disease
24 April 2012, 4:40 am
A recent clinical trial conducted at Evergreen Healthcare shows that a new form of a common drug used to treat Parkinson's Disease greatly improves the quality of life for patients and reduces the affects of symptoms such as tremors, slowness, stiffness and difficulty walking.

Wockhardt launches generic Parkinson’s treatment drug in US
24 April 2012, 2:26 am
Wockhardt said on Tuesday that it has launched a generic version of Orion Corporation’s Parkinson’s treatment drug Stalevo in the US, with 180 days of marketing exclusivity.